Mylan (NASDAQ: MYL) has recently received a number of price target changes and ratings updates:

  • 11/29/2016 – Mylan had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $55.00 price target on the stock.
  • 11/18/2016 – Mylan had its price target lowered by analysts at Mizuho from $49.00 to $47.00. They now have a “buy” rating on the stock.
  • 11/10/2016 – Mylan had its “hold” rating reaffirmed by analysts at Barclays PLC. They now have a $44.00 price target on the stock.
  • 11/10/2016 – Mylan had its “sector perform” rating reaffirmed by analysts at RBC Capital Markets. They now have a $44.00 price target on the stock, down previously from $48.00.
  • 10/26/2016 – Mylan is now covered by analysts at Mizuho. They set a “buy” rating and a $49.00 price target on the stock.
  • 10/10/2016 – Mylan was upgraded by analysts at Raymond James Financial Inc. from a “market perform” rating to a “strong-buy” rating. They now have a $57.00 price target on the stock.
  • 10/10/2016 – Mylan had its “sector perform” rating reaffirmed by analysts at RBC Capital Markets. They now have a $48.00 price target on the stock.
  • 10/10/2016 – Mylan had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $55.00 price target on the stock.
  • 10/10/2016 – Mylan was given a new $52.00 price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 10/4/2016 – Mylan was given a new $52.00 price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 10/1/2016 – Mylan was given a new $44.00 price target on by analysts at Wells Fargo & Co.. They now have a “hold” rating on the stock.
  • 10/1/2016 – Mylan was given a new $45.00 price target on by analysts at Leerink Swann. They now have a “buy” rating on the stock.

Mylan Inc. (NASDAQ:MYL) opened at 36.06 on Wednesday. The firm has a market capitalization of $19.30 billion, a P/E ratio of 72.26 and a beta of 1.10. Mylan Inc. has a 1-year low of $33.60 and a 1-year high of $55.51. The stock has a 50 day moving average of $37.27 and a 200-day moving average of $42.19.

Mylan (NASDAQ:MYL) last issued its quarterly earnings results on Wednesday, November 9th. The company reported $1.38 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by $0.07. The company earned $3.06 billion during the quarter, compared to analyst estimates of $3.12 billion. Mylan had a net margin of 2.50% and a return on equity of 22.04%. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.43 EPS. On average, equities research analysts anticipate that Mylan Inc. will post $4.76 earnings per share for the current year.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

5 Day Chart for NASDAQ:MYL

Receive News & Ratings for Mylan Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan Inc and related companies with MarketBeat.com's FREE daily email newsletter.